Concepedia

Marion Dorsch

MD

Statistics

Publications

61

Citations

8.1K

H-Index

40

Active since

1991

Affiliations

Agios Pharmaceuticals (United States)(Current)

Millennium Engineering and Integration (United States)

Novartis (United States)

Blueprint Medicines (United States)

Freie Universität Berlin

Marion Dorsch is an author at Agios Pharmaceuticals (United States) specializing in molecular oncology, oncology, and medicine.

Publications per year

1991–2024

61

Publications

61

Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation

Fang Wang, Jeremy Travins, Byron DeLaBarre et al. · Science · 2013 · 797 citations

Medicine, Cancer Biology, Oncology +10

Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma

Silvia Buonamici, Juliet Williams, Michael Morrissey et al. · Science Translational Medicine · 2010 · 554 citations

Medicine, Oncology, Pharmacology +16

Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate

Lukas Bunse, Stefan Pusch, Theresa Bunse et al. · Nature Medicine · 2018 · 537 citations

Life Sciences, Immunology, Oncology +12

Identification and Characterization of NVP-BKM120, an Orally Available Pan-Class I PI3-Kinase Inhibitor

Sauveur-Michel Maira, Sabina Pecchi, Alan Huang et al. · Molecular Cancer Therapeutics · 2011 · 529 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

A Primary Xenograft Model of Small-Cell Lung Cancer Reveals Irreversible Changes in Gene Expression Imposed by Culture <i>In vitro</i>

Vincent C. Daniel, Luigi Marchionni, Jared S. Hierman et al. · Cancer Research · 2009 · 478 citations · Full text

Medicine, Cell Biology, Oncology +12

1–5 of 61